Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)

Overview of attention for article published in Journal of the American Academy of Dermatology, December 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 2 news outlets
twitter: 8 X users
patent: 16 patents
facebook: 7 Facebook pages

reddit: 2 Redditors
f1000: 1 research highlight platform
guideline: 1 clinical guideline source

Readers on

mendeley: 125 Mendeley

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 87,071 followers.

@MauriceOnTW No large trove of data I’m aware of, but may have missed it. https://t.co/75iPpmCLBD https://t.co/D0i9iuMwY7

RT @SergioVanoG: El fármaco #ruxolitinib, útil para #alopecia #areata, también útil para #vitíligo. https://t.co/NKYuKuH0d8 https://t.co/Rv…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.